• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与同时启动促性腺激素释放激素激动剂和促卵泡激素进行卵母细胞募集相关的卵泡闭锁

Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment.

作者信息

Brzyski R G, Muasher S J, Droesch K, Simonetti S, Jones G S, Rosenwaks Z

机构信息

Howard and Georgeanna Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk 23507.

出版信息

Fertil Steril. 1988 Dec;50(6):917-21. doi: 10.1016/s0015-0282(16)60372-2.

DOI:10.1016/s0015-0282(16)60372-2
PMID:3144467
Abstract

The ability of gonadotropin-releasing hormone agonist (GnRHa) to cause an initial stimulation of serum gonadotropins was used for follicular recruitment for in vitro fertilization (IVF) in 12 patients with a history of low estradiol (E2) response to conventional gonadotropin stimulation. Stimulation was initiated on cycle day 3 with concurrent administration of leuprolide (1 mg/day subcutaneously) and follicle stimulating hormone (FSH, 4 ampules/day intramuscularly). An 8-fold increase in basal serum luteinizing hormone (LH) and a 4-fold increase in basal serum FSH was seen on cycle day 4. Serum progesterone levels rose significantly by day 6. When compared to prior IVF attempts in these patients, the mean day of human chorionic gonadotropin administration and corresponding E2 levels were not significantly different. More atretic oocytes and fewer preovulatory oocytes were retrieved using GnRHa, and no increase was seen in total oocytes retrieved. One patient was canceled for poor E2 response, and one patient conceived, with a current viable pregnancy. It is concluded that concurrent initiation of leuprolide and FSH stimulation on cycle day 3 in patients with prior low response does not improve oocyte recruitment, and the high LH environment generated from initial stimulation of the agonist may be detrimental to normal oocyte development.

摘要

对于12例既往对传统促性腺激素刺激雌二醇(E2)反应低下的患者,促性腺激素释放激素激动剂(GnRHa)引发血清促性腺激素初始刺激的能力被用于体外受精(IVF)的卵泡募集。在月经周期第3天开始刺激,同时皮下注射亮丙瑞林(1mg/天)和肌肉注射促卵泡激素(FSH,4支/天)。在月经周期第4天,基础血清黄体生成素(LH)增加了8倍,基础血清FSH增加了4倍。到第6天血清孕酮水平显著升高。与这些患者之前的IVF尝试相比,人绒毛膜促性腺激素给药的平均日期和相应的E2水平没有显著差异。使用GnRHa获取的闭锁卵泡更多,排卵前卵泡更少,获取的卵泡总数未见增加。1例患者因E2反应差而取消,1例患者怀孕,目前为活胎妊娠。结论是,对于既往反应低下的患者,在月经周期第3天同时开始亮丙瑞林和FSH刺激并不能改善卵泡募集,激动剂初始刺激产生的高LH环境可能对正常卵泡发育有害。

相似文献

1
Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment.与同时启动促性腺激素释放激素激动剂和促卵泡激素进行卵母细胞募集相关的卵泡闭锁
Fertil Steril. 1988 Dec;50(6):917-21. doi: 10.1016/s0015-0282(16)60372-2.
2
Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.在体外受精的促性腺激素刺激之前使用促性腺激素释放激素激动剂进行抑制的价值。
Fertil Steril. 1989 Feb;51(2):292-7. doi: 10.1016/s0015-0282(16)60493-4.
3
Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.在接受控制性卵巢过度刺激的女性中,促性腺激素释放激素拮抗剂与激动剂给药的比较:周期表现及颗粒黄体细胞的体外类固醇生成
Am J Obstet Gynecol. 1995 May;172(5):1518-25. doi: 10.1016/0002-9378(95)90490-5.
4
Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.在高反应患者中使用纯促卵泡激素联合或不联合促性腺激素释放激素激动剂进行体外受精的卵巢刺激。
J In Vitro Fert Embryo Transf. 1990 Jun;7(3):172-6. doi: 10.1007/BF01135684.
5
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.在接受重组促卵泡激素和促性腺激素释放激素(GnRH)拮抗剂联合治疗进行卵巢刺激后的体外受精患者中,给予重组人绒毛膜促性腺激素、重组促黄体生成素或GnRH激动剂诱导最终卵母细胞成熟后,未补充黄体期的特征。
J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953.
6
An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.“反应不良者”控制性卵巢过度刺激的另一种方法:用促性腺激素释放激素类似物进行预处理。
Fertil Steril. 1988 Jan;49(1):90-5. doi: 10.1016/s0015-0282(16)59655-1.
7
The efficacy of a combination administration of gonadotropin-releasing hormone agonist and gonadotropins for controlled ovarian hyperstimulation in IVF program.促性腺激素释放激素激动剂与促性腺激素联合给药在体外受精程序中用于控制性卵巢过度刺激的疗效。
Asia Oceania J Obstet Gynaecol. 1990 Dec;16(4):337-45. doi: 10.1111/j.1447-0756.1990.tb00358.x.
8
Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.在 GnRH 拮抗剂体外受精周期中,基础血清孕酮水平以及人绒毛膜促性腺激素(hCG)给药当天孕酮升高的病史是卵泡期晚期孕酮升高的重要预测指标。
Hum Reprod. 2016 Aug;31(8):1859-65. doi: 10.1093/humrep/dew141. Epub 2016 Jun 14.
9
Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.卵泡期促性腺激素释放激素激动剂与人促性腺激素:体外受精中诱导排卵的更好选择。
Fertil Steril. 1990 Feb;53(2):302-5. doi: 10.1016/s0015-0282(16)53285-3.
10
The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome.基础和/或刺激后的血清促性腺激素水平在预测刺激反应及体外受精结局中的价值。
Fertil Steril. 1988 Aug;50(2):298-307. doi: 10.1016/s0015-0282(16)60077-8.

引用本文的文献

1
Enhancing the fertility of poor responders by treatment with estrogen rebound combined with a short protocol.采用雌激素反跳联合短方案治疗提高低反应者的生育力。
Reprod Med Biol. 2003 Sep 26;2(3):127-131. doi: 10.1046/j.1445-5781.2003.00033.x. eCollection 2003 Sep.
2
Day 3 embryo transfer may have better pregnancy outcomes in younger than 35-year-old patients with poor ovarian response.对于卵巢反应不良的 35 岁以下年轻患者,第 3 天胚胎移植可能会获得更好的妊娠结局。
J Assist Reprod Genet. 2012 Oct;29(10):1077-81. doi: 10.1007/s10815-012-9830-y. Epub 2012 Jul 20.
3
Management of the poor responder: the role of GnRH agonists and antagonists.
低反应者的管理:促性腺激素释放激素激动剂和拮抗剂的作用
J Assist Reprod Genet. 2007 Dec;24(12):613-9. doi: 10.1007/s10815-007-9180-3. Epub 2007 Nov 29.
4
Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles.口服避孕药引起的下丘脑-垂体抑制并不能改善体外受精-胚胎移植周期中反应不良患者的治疗结局。
J Assist Reprod Genet. 2001 Jul;18(7):391-4. doi: 10.1023/a:1016626607387.
5
Comparative analysis of the effects of gonadotropin-releasing hormone agonist on the proliferative activity, apoptosis, and steroidogenesis in cultured porcine granulosa cells at varying stages of follicular growth.促性腺激素释放激素激动剂对不同卵泡生长阶段培养的猪颗粒细胞增殖活性、凋亡及类固醇生成影响的比较分析
Endocrine. 2000 Feb;12(1):61-7. doi: 10.1385/ENDO:12:1:61.
6
Effectiveness of low dose of gonadotropin releasing hormone agonist on hormonal flare-up.低剂量促性腺激素释放激素激动剂对激素 flare-up 的有效性。 (注:这里“flare-up”可能是医学上特定的术语,在不同语境下有不同确切含义,比如“激素波动”“激素突发反应”等,具体需结合完整医学背景来准确理解。)
J Assist Reprod Genet. 2000 Feb;17(2):113-7. doi: 10.1023/a:1009470101732.
7
Treatment of low responders.低反应者的治疗。
J Assist Reprod Genet. 1993 Feb;10(2):112-4. doi: 10.1007/BF01207730.
8
Cycle characteristics and outcome in relation to ovarian response during in vitro fertilization.体外受精过程中与卵巢反应相关的周期特征及结局
J Assist Reprod Genet. 1993 Nov;10(8):504-12. doi: 10.1007/BF01204360.
9
Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.
J In Vitro Fert Embryo Transf. 1989 Dec;6(6):345-52. doi: 10.1007/BF01138775.
10
The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles.促性腺激素释放激素激动剂(醋酸亮丙瑞林)联合促性腺激素在体外受精和配子输卵管内移植周期中用于控制性卵巢过度刺激的优势。
Arch Gynecol Obstet. 1989;246 Suppl:S45-52. doi: 10.1007/BF00935852.